299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

6 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04580368 (ClinicalTrials.gov)	March 30, 2022	2/10/2020	Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials	Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials	Cystic Fibrosis	Drug: CFTR Modulators	Children's Hospital Medical Center, Cincinnati	NULL	Not yet recruiting	6 Years	N/A	All	50	N/A	NULL
2	NCT04415268 (ClinicalTrials.gov)	June 9, 2020	28/5/2020	Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis	Combined Effect of CFTR Protein Modulator Drugs and Exercise on Pulmonary Function, Fitness, Sweat Test and Quality of Life in Children With Cystic Fibrosis	Cystic Fibrosis in Children	Behavioral: Exercise;Behavioral: Unsupervised exercise;Drug: CFTR Modulators	Universidad Europea de Madrid	NULL	Recruiting	6 Years	18 Years	All	11	N/A	Spain
3	NCT04301856 (ClinicalTrials.gov)	January 1, 2020	21/2/2020	Response to CFTR Modulators in CF Patients Under 18 Years	Evaluation of the Response to CFTR Modulators in Patients With Cystic Fibrosis Less Than 18 Years of Age	Cystic Fibrosis in Children	Drug: CFTR Modulators	Societe Francaise de la Mucoviscidose	NULL	Recruiting	N/A	18 Years	All	600		France
4	NCT04206436 (ClinicalTrials.gov)	December 18, 2019	18/12/2019	CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis	CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis	Cystic Fibrosis;Bone Loss;Muscle Loss	Drug: Cftr Modulators	Indiana University	Cystic Fibrosis Foundation	Enrolling by invitation	18 Years	N/A	All	60		United States
5	NCT03506061 (ClinicalTrials.gov)	September 4, 2019	13/4/2018	Trikafta in Cystic Fibrosis Patients	iPS Cell Response to CFTR Modulators: Study of Trikafta in CF Patients Carrying Partial Function Mutations	Cystic Fibrosis	Drug: Trikafta	Emory University	National Heart, Lung, and Blood Institute (NHLBI)	Recruiting	12 Years	N/A	All	22	Phase 2	United States
6	NCT01348204 (ClinicalTrials.gov)	March 2010	1/6/2010	Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators	Nasal Potential Studies Utilizing CFTR Modulators (UAB Center for Clinical and Translational Science)	Cystic Fibrosis	Other: quercetin	University of Alabama at Birmingham	National Institutes of Health (NIH)	Completed	8 Years	65 Years	Both	32	Phase 2	United States

先頭へ